Latest Insider Transactions at Amerisourcebergen Corp (ABC)
This section provides a real-time view of insider transactions for Amerisourcebergen Corp (ABC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of AMERISOURCEBERGEN CORP to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of AMERISOURCEBERGEN CORP's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 22
2024
|
Steven H Collis Executive Chairman |
SELL
Open market or private sale
|
Direct |
21,509
-7.02%
|
$5,054,615
$235.8 P/Share
|
|
Oct 22
2024
|
Steven H Collis Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
21,509
+6.56%
|
$1,914,301
$89.58 P/Share
|
|
Sep 17
2024
|
Steven H Collis Executive Chairman |
SELL
Open market or private sale
|
Direct |
21,509
-7.02%
|
$5,183,669
$241.01 P/Share
|
|
Sep 17
2024
|
Steven H Collis Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
21,509
+6.56%
|
$1,914,301
$89.58 P/Share
|
|
Aug 20
2024
|
Steven H Collis Executive Chairman |
SELL
Open market or private sale
|
Direct |
10,754
-3.64%
|
$2,570,206
$239.13 P/Share
|
|
Aug 20
2024
|
Steven H Collis Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
10,754
+3.51%
|
$957,106
$89.58 P/Share
|
|
Aug 06
2024
|
Silvana Battaglia Executive Vice President |
SELL
Open market or private sale
|
Direct |
1,473
-11.86%
|
$356,466
$242.69 P/Share
|
|
Aug 05
2024
|
Lon R Greenberg Director |
SELL
Bona fide gift
|
Direct |
5,000
-19.95%
|
-
|
|
Aug 01
2024
|
Walgreens Boots Alliance, Inc. |
SELL
Open market or private sale
|
Indirect |
4,438,171
-18.18%
|
$1,065,161,040
$240.56 P/Share
|
|
Aug 01
2024
|
Werner Baumann Director |
BUY
Grant, award, or other acquisition
|
Direct |
103
+5.48%
|
$25,132
$244.46 P/Share
|
|
Aug 01
2024
|
Dennis M Nally Director |
BUY
Grant, award, or other acquisition
|
Direct |
128
+1.05%
|
$31,232
$244.46 P/Share
|
|
Aug 01
2024
|
Lauren M Tyler Director |
BUY
Grant, award, or other acquisition
|
Direct |
103
+5.48%
|
$25,132
$244.46 P/Share
|
|
Jul 16
2024
|
Steven H Collis Executive Chairman |
SELL
Open market or private sale
|
Direct |
10,755
-3.64%
|
$2,387,610
$222.12 P/Share
|
|
Jul 16
2024
|
Steven H Collis Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
10,755
+3.51%
|
$957,195
$89.58 P/Share
|
|
Jul 01
2024
|
Leslie E Donato EVP & Chief Strategy Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
533
-5.34%
|
$124,189
$233.53 P/Share
|
|
Jul 01
2024
|
Leslie E Donato EVP & Chief Strategy Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,432
+12.54%
|
-
|
|
Jun 28
2024
|
Elizabeth S Campbell Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
57
+0.68%
|
$10,887
$191.5 P/Share
|
|
Jun 28
2024
|
Silvana Battaglia Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
66
+0.53%
|
$12,606
$191.5 P/Share
|
|
Jun 28
2024
|
Leslie E Donato EVP & Chief Strategy Officer |
BUY
Grant, award, or other acquisition
|
Direct |
66
+0.69%
|
$12,606
$191.5 P/Share
|
|
Jun 18
2024
|
Steven H Collis Executive Chairman |
SELL
Open market or private sale
|
Direct |
10,754
-3.64%
|
$2,527,190
$235.76 P/Share
|
|
Jun 18
2024
|
Steven H Collis Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
10,754
+3.51%
|
$957,106
$89.58 P/Share
|
|
May 31
2024
|
Gina Clark Executive Vice President |
SELL
Open market or private sale
|
Direct |
1,874
-12.36%
|
$417,902
$223.86 P/Share
|
|
May 29
2024
|
Gina Clark Executive Vice President |
SELL
Open market or private sale
|
Direct |
27,093
-64.12%
|
$5,852,088
$216.07 P/Share
|
|
May 29
2024
|
Gina Clark Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
27,093
+39.07%
|
$2,329,998
$86.09 P/Share
|
|
May 24
2024
|
Dermot Mark Durcan Director |
BUY
Open market or private purchase
|
Direct |
500
+2.23%
|
$109,000
$218.58 P/Share
|
|
May 22
2024
|
Walgreens Boots Alliance, Inc. |
SELL
Open market or private sale
|
Indirect |
1,859,390
-7.08%
|
$399,768,850
$215.12 P/Share
|
|
May 21
2024
|
Steven H Collis Executive Chairman |
SELL
Open market or private sale
|
Direct |
10,755
-3.64%
|
$2,376,855
$221.3 P/Share
|
|
May 21
2024
|
Steven H Collis Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
10,755
+3.51%
|
$957,195
$89.58 P/Share
|
|
May 01
2024
|
Lauren M Tyler Director |
BUY
Grant, award, or other acquisition
|
Direct |
110
+6.17%
|
$25,190
$229.2 P/Share
|
|
May 01
2024
|
Dennis M Nally Director |
BUY
Grant, award, or other acquisition
|
Direct |
137
+1.13%
|
$31,373
$229.2 P/Share
|
|
May 01
2024
|
Werner Baumann Director |
BUY
Grant, award, or other acquisition
|
Direct |
110
+6.17%
|
$25,190
$229.2 P/Share
|
|
Apr 16
2024
|
Steven H Collis Executive Chairman |
SELL
Open market or private sale
|
Direct |
10,754
-3.64%
|
$2,548,698
$237.48 P/Share
|
|
Apr 16
2024
|
Steven H Collis Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
10,754
+3.51%
|
$957,106
$89.58 P/Share
|
|
Apr 15
2024
|
Robert P. Mauch Executive Vice President & COO |
SELL
Open market or private sale
|
Direct |
57,564
-70.22%
|
$13,527,540
$235.09 P/Share
|
|
Apr 15
2024
|
Robert P. Mauch Executive Vice President & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
33,877
+29.24%
|
$3,015,053
$89.58 P/Share
|
|
Mar 19
2024
|
Steven H Collis Executive Chairman |
SELL
Open market or private sale
|
Direct |
10,755
-3.64%
|
$2,581,200
$240.21 P/Share
|
|
Mar 19
2024
|
Steven H Collis Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
10,755
+3.51%
|
$957,195
$89.58 P/Share
|
|
Mar 18
2024
|
Gina Clark Executive Vice President |
SELL
Open market or private sale
|
Direct |
9,644
-38.88%
|
$2,295,272
$238.12 P/Share
|
|
Mar 18
2024
|
Elizabeth S Campbell Executive Vice President |
SELL
Open market or private sale
|
Direct |
6,977
-45.83%
|
$1,660,526
$238.12 P/Share
|
|
Mar 12
2024
|
Lorence H. Kim Director |
BUY
Grant, award, or other acquisition
|
Direct |
843
+23.56%
|
-
|
|
Mar 12
2024
|
Richard W Gochnauer Director |
BUY
Grant, award, or other acquisition
|
Direct |
843
+2.85%
|
-
|
|
Mar 12
2024
|
Dermot Mark Durcan Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,053
+4.69%
|
-
|
|
Mar 12
2024
|
Dennis M Nally Director |
BUY
Grant, award, or other acquisition
|
Direct |
843
+6.66%
|
-
|
|
Mar 12
2024
|
Lon R Greenberg Director |
BUY
Grant, award, or other acquisition
|
Direct |
843
+3.02%
|
-
|
|
Mar 12
2024
|
Kathleen W Hyle Director |
BUY
Grant, award, or other acquisition
|
Direct |
843
+3.34%
|
-
|
|
Mar 12
2024
|
Redonda Miller Director |
BUY
Grant, award, or other acquisition
|
Direct |
843
+25.95%
|
-
|
|
Mar 12
2024
|
Werner Baumann Director |
BUY
Grant, award, or other acquisition
|
Direct |
843
+35.04%
|
-
|
|
Mar 12
2024
|
Lauren M Tyler Director |
BUY
Grant, award, or other acquisition
|
Direct |
843
+35.04%
|
-
|
|
Mar 11
2024
|
Richard W Gochnauer Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,593
+5.4%
|
-
|
|
Mar 11
2024
|
Dermot Mark Durcan Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,593
+7.27%
|
-
|